The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 743K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy.EBI
Mcmaster University
Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).EBI
Mcmaster University
Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).EBI
Mcmaster University
Structural-functional studies of Burkholderia cenocepacia D-glycero-ß-D-manno-heptose 7-phosphate kinase (HldA) and characterization of inhibitors with antibiotic adjuvant and antivirulence properties.EBI
Mcmaster University
Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.EBI
Mcmaster University
Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function.EBI
Mcmaster University
High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.EBI
Mcmaster University
Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).EBI
Mcmaster University
Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.EBI
Mcmaster University
Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs.EBI
Mcmaster University
Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4.EBI
Mcmaster University
Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.EBI
Mcmaster University
Identification of small molecule chemical inhibitors of the collagen-specific chaperone Hsp47.EBI
Mcmaster University
Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.EBI
Mcmaster University
High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.EBI
Mcmaster University
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.EBI
Mcmaster University
Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors (methionine aminopeptidase type-2)BDB
Sanofi
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275.BDB
Pfizer